Neurology & Neuroscience


A Phase II, Randomized, Double-Blind, Placebo-controlled, 24-week Dose Finding Study to evaluate the Efficacy and Safety of 20 mg

Investigator: Brannagan, Thomas H
Phone Number: 212-888-8516


A doubled-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine...Diabetic Neuropathy

Investigator: Brannagan, Thomas H
Phone Number: 212-888-8516


Long-Term Safety & Efficacy Study of Open-Label Treatment with 80 mg of MCC-257 in Patients with Mild to Moderate Diabetic Polyneuropathy

Investigator: Brannagan, Thomas H
Phone Number: 212-888-8516


A Double-Blind, Placebo-Controlled, Parallel-Group Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial Seizures

Investigator: Harden, Cynthia L
Phone Number: x6-2346


A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RWJ-333369 ...

Investigator: Harden, Cynthia L
Phone Number: x6-2346


An Open-Label, Multicenter, Follow-Up Trial to Evaluate the Long-Term Safety and Efficacy of Brivaracetam as Adjunctive Treatment at a Flexible Dose

Investigator: Harden, Cynthia L
Phone Number: x6-2346


An Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral SPM 927 in Patients with Partial Seizures

Investigator: Harden, Cynthia L
Phone Number: x6-2346


NEAD - Neurodevelopment Effects of Antiepileptic Drugs

Investigator: Harden, Cynthia L
Phone Number: x6-2346


NEAD-Neurodevelopment Effects of Antiepileptic Drugs

Investigator: Harden, Cynthia L
Phone Number: x6-2346


Progesterone Therapy versus Placebo for Women with Epilepsy

Investigator: Harden, Cynthia L
Phone Number: x6-2346


Randomized Evaluation of Long term anticoagulant therapy (RE-LY) comparing the efficacy and safety of two blinded doses dabigatran . . .

Investigator: Jamieson, Dara G
Phone Number: 746-6575


Automated Response to Spontaneous Epileptiform Activity Using the External Responsive Neurostimulator System (eRNS)

Investigator: Kobylarz, Erik J
Phone Number: x6-2014


Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy

Investigator: Labar, Douglas R
Phone Number: x6-2337


Prospective Seizure Frequency Clinical Investigation (Protocol #1103-051)

Investigator: Labar, Douglas R
Phone Number: x6-2337


Responsive Neurostimulator (RNS) System Long-Term Treatment Clinical Investigation

Investigator: Labar, Douglas R
Phone Number: x6-2337


Responsive Neurostimulator System Feasibility Clinical Investigation

Investigator: Labar, Douglas R
Phone Number: x6-2337


Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE) Protocol 1604

Investigator: Labar, Douglas R
Phone Number: x6-2337


SPOTRIAS: Neuroprotection with Statin Therapy for Acute Recovery Trial

Investigator: Leifer, Dana
Phone Number: 746-6575


Study of Acute Viprinex for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex) in Subjects Beginning ...

Investigator: Leifer, Dana
Phone Number: 746-6575


Randomized, Double-Blind, Active (Pramipexole 0.5mg tid) & Placebo Controlled, Efficacy Study of Pramipexole, Given 0.5mg & 0.75mg Bid Over a 12-week.

Investigator: Nirenberg, Melissa J.
Phone Number: 746-6575


A Placebo-Controlled, Randomized, Rater-Blinded Phase II Clinical Study of Gammagard Intravenous Innumoglobulin (IVIg)...

Investigator: Relkin, Norman R
Phone Number: x6-6581


A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-center Trial of Pregabalin versus Placebo in the Treatment of Neuropathic...

Investigator: Rubin, Michael
Phone Number: x6-2320


An Open-Label, Extension Safety and Efficacy Trial of Pregabalin in Subjects with Neuropathic Pain Associated with HIV Neuropathy ...

Investigator: Rubin, Michael
Phone Number: x6-2320


Central Processing of Visual Information

Investigator: Victor, Jonathan D
Phone Number: x6-2276



 
Back to Top